FEASIBILITY COMPONENT Sample Clauses

FEASIBILITY COMPONENT. 1. Arena Obligations. Arena shall, within fifteen (15) days of the Effective Date, provide to Lexicon two (2) human G protein coupled receptors (GPCR) that have been subjected to Arena's CART Technology, with one (1) GPCR for which the endogenous ligand is known (the "Known GPCR"), and the other GPCR for which the endogenous ligand is not known (the "Orphan GPCR"). The receptors provided by Arena to Lexicon shall be in a form appropriate for use by Lexicon as contemplated herein. All costs and liability borne by Arena for Arena Obligations shall be the obligation of Arena. During the Feasibility Component, Arena shall use best reasonable commercial efforts to complete: development of screening assays comprising the Known GPCR and the Orphan GPCR; screening of Arena's internal chemical library using assays comprising the Known GPCR and the Orphan GPCR; and selection of at least one chemical compound for in vivo analysis ("In Vivo Compounds - Feasibility"). Arena shall use best reasonable commercial efforts to provide sufficient quantities of such In Vivo Compounds - Feasibility to Lexicon for in vivo analysis thereof, such in vivo analysis by Lexicon to be restricted exclusively to the animals of Section 1(A)(2). (i). With respect to the Known GPCR, the Parties agree that the Known Receptor shall not be included within the Alliance Component of Section 1(B), and that Lexicon shall have no rights to, inter alia, such Known Receptor or any assays comprising the Known Receptor or any chemical compounds developed by Arena (and/or any partner of Arena) using such Known Receptor. (ii). With respect to the Orphan GPCR, the Parties agree that if the Alliance Component of Section 1(B) is initiated, then such Orphan Receptor shall be included as a part of